Literature DB >> 21903966

Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability.

Giuseppe Straface1, Federico Biscetti, Dario Pitocco, Giovanni Bertoletti, Maria Misuraca, Claudio Vincenzoni, Francesco Snider, Vincenzo Arena, Egidio Stigliano, Flavia Angelini, Luigi Iuliano, Stefania Boccia, Chiara de Waure, Francesco Giacchi, Giovanni Ghirlanda, Andrea Flex.   

Abstract

BACKGROUND AND
PURPOSE: Osteoprotegerin (OPG) is a secretory glycoprotein which belongs to the tumor necrosis factor receptor family. Various mechanisms have been suggested by which calcification might alter atherosclerotic plaque stability, but the significance of this intimal calcification is controversial. High concentrations of OPG have been associated with the presence of vascular and cardiovascular diseases. This study was designed to assess the association between gene polymorphisms of the OPG gene (TNFRSF11B), the serum OPG level, and plaque stability in patients with carotid atherosclerosis.
METHODS: We studied 177 patients with internal carotid artery stenosis who underwent carotid endarterectomy and also 303 controls. Carotid endarterectomy samples removed from patients were assessed by immunohistochemistry. Concentrations of OPG were measured and gene polymorphisms were examined by polymerase chain reaction and restriction enzyme analysis and were compared, initially between patients with carotid atherosclerosis and controls, and subsequently between stable and unstable carotid plaques.
RESULTS: We found that the GG genotype of the T245G polymorphism, the CC genotype of the T950C polymorphism, and the CC genotype of the G1181C polymorphism were significantly higher in patients with carotid plaque than in controls (21.5% versus 10.9% , P<0.01; 15.8% versus 7.6%, P<0.01; and 20.3% versus 10.9%, P<0.01, respectively) and that these polymorphisms were associated with high serum OPG levels (4.02 [3.07] versus 2.94 [1.81] pmol/L; P<0.01), which were significantly higher in patients with unstable atherosclerotic plaques (5.86 [4.02] versus 3.53 [1.87] pmol/L; P<0.01).
CONCLUSIONS: The TNFRSF11B gene polymorphisms studied are associated with high serum OPG levels and might be potential markers for plaque instability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903966     DOI: 10.1161/STROKEAHA.111.619288

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

1.  Association Between Serum Selenium Concentration and OPG/RANKL/RANK Axis in Patients with Arterial Hypertension.

Authors:  Karolina Czerwińska; Małgorzata Poręba; Adam Prokopowicz; Lidia Januszewska; Aleksandra Jaremków; Iwona Markiewicz-Górka; Helena Martynowicz; Grzegorz Mazur; Rafał Poręba; Krystyna Pawlas; Paweł Gać
Journal:  Cardiovasc Toxicol       Date:  2022-04-12       Impact factor: 3.231

2.  Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients.

Authors:  Federico Biscetti; Giuseppe Straface; Silvia Giovannini; Angelo Santoliquido; Flavia Angelini; Luca Santoro; Carlo Filippo Porreca; Giovanni Pecorini; Giovanni Ghirlanda; Andrea Flex
Journal:  Hum Genet       Date:  2012-09-11       Impact factor: 4.132

3.  Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).

Authors:  R M R Pereira; C P Figueiredo; C C Cha; V F Caparbo; R M Oliveira; A S Franco; P R Menezes; I de Castro; L F Onuchic
Journal:  Osteoporos Int       Date:  2016-06-16       Impact factor: 4.507

4.  Correlation of single nucleotide polymorphisms in the pregnancy-associated plasma protein-A gene with carotid plaques.

Authors:  Shiming Zhou; Min Cui; Zegang Yin; Rui Li; Jie Zhu; Huadong Zhou
Journal:  BMC Cardiovasc Disord       Date:  2015-06-30       Impact factor: 2.298

5.  Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients.

Authors:  Changlei Guo; Fudong Hu; Shaoli Zhang; Yakun Wang; Hengdao Liu
Journal:  Genet Mol Biol       Date:  2013-05-17       Impact factor: 1.771

6.  Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis.

Authors:  Fernanda Genre; Raquel López-Mejías; Mercedes García-Bermúdez; Santos Castañeda; Carlos González-Juanatey; Javier Llorca; Alfonso Corrales; Begoña Ubilla; José A Miranda-Filloy; Trinitario Pina; Carmen Gómez-Vaquero; Luis Rodríguez-Rodríguez; Benjamín Fernández-Gutiérrez; Alejandro Balsa; Dora Pascual-Salcedo; Francisco J López-Longo; Patricia Carreira; Ricardo Blanco; Isidoro González-Álvaro; Javier Martín; Miguel A González-Gay
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

7.  A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study.

Authors:  Cecilia P Chung; Joseph F Solus; Annette Oeser; Chun Li; Paolo Raggi; Jeffrey R Smith; C Michael Stein
Journal:  Int J Mol Sci       Date:  2015-02-11       Impact factor: 5.923

8.  Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability.

Authors:  Jean-Michel Davaine; Thibaut Quillard; Régis Brion; Olivier Lapérine; Béatrice Guyomarch; Thierry Merlini; Mathias Chatelais; Florian Guilbaud; Meadhbh Áine Brennan; Céline Charrier; Dominique Heymann; Yann Gouëffic; Marie-Françoise Heymann
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

9.  Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis.

Authors:  Federico Biscetti; Giuseppe Straface; Carlo Filippo Porreca; Giovanni Bertoletti; Claudio Vincenzoni; Francesco Snider; Egidio Stigliano; Vincenzo Arena; Flavia Angelini; Giovanni Pecorini; Antonio Bianchi; Raffaele Landolfi; Andrea Flex
Journal:  Cardiovasc Diabetol       Date:  2015-10-12       Impact factor: 9.951

Review 10.  Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications.

Authors:  Mette Bjerre
Journal:  Springerplus       Date:  2013-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.